Regeneron is speeding up the development of a therapy against COVID-19. Investors welcomed the news by bidding up company stock.
The post This Biotech Stock Is Surging Over Potential COVID-19 Drug appeared first on CCN.com
Source and More information: This Biotech Stock Is Surging Over Potential COVID-19 Drug
Author: CryptoCoinsNews.com
Leave a Reply